Hoth Therapeutics, Inc. (NASDAQ: HOTH), a leading biopharmaceutical company focused on patient-centric solutions, today shared encouraging interim safety and efficacy results from its Phase 2a ...
Quench your skin’s thirst with the right ingredients this winter and beyond. Tue, 07 Jan, 2025 - 18:00 One of the top requirements for skincare aimed at dry skin is that it makes the skin feel nice.
While Hoth Therapeutics has always been an up-and-comer in the world of biotech, the spotlight is now firmly on them due to the CLEER-001 trial, where early results from the HT-001 treatment are ...